Type 1 Diabetes Risk in African-Ancestry Participants and Utility of an Ancestry-Specific Genetic Risk Score - PubMed
. 2019 Mar;42(3):406-415.
doi: 10.2337/dc18-1727. Epub 2019 Jan 18.
Wei-Min Chen 1 2 , Catherine C Robertson 1 , Jessica K Bonnie 1 , Emily Farber 1 , Zhennan Zhu 1 , Jorge R Oksenberg 3 , Steven R Brant 4 , S Louis Bridges Jr 5 , Jeffrey C Edberg 5 , Robert P Kimberly 5 , Peter K Gregersen 6 , Marian J Rewers 7 , Andrea K Steck 7 , Mary H Black 8 , Dana Dabelea 9 , Catherine Pihoker 10 , Mark A Atkinson 11 , Lynne E Wagenknecht 12 , Jasmin Divers 13 , Ronny A Bell 12 ; SEARCH for Diabetes in Youth; Type 1 Diabetes Genetics Consortium; Henry A Erlich 14 , Patrick Concannon 1 , Stephen S Rich 15 2
Affiliations
- PMID: 30659077
- PMCID: PMC6385701
- DOI: 10.2337/dc18-1727
Type 1 Diabetes Risk in African-Ancestry Participants and Utility of an Ancestry-Specific Genetic Risk Score
Suna Onengut-Gumuscu et al. Diabetes Care. 2019 Mar.
Abstract
Objective: Genetic risk scores (GRS) have been developed that differentiate individuals with type 1 diabetes from those with other forms of diabetes and are starting to be used for population screening; however, most studies were conducted in European-ancestry populations. This study identifies novel genetic variants associated with type 1 diabetes risk in African-ancestry participants and develops an African-specific GRS.
Research design and methods: We generated single nucleotide polymorphism (SNP) data with the ImmunoChip on 1,021 African-ancestry participants with type 1 diabetes and 2,928 control participants. HLA class I and class II alleles were imputed using SNP2HLA. Logistic regression models were used to identify genome-wide significant (P < 5.0 × 10-8) SNPs associated with type 1 diabetes in the African-ancestry samples and validate SNPs associated with risk in known European-ancestry loci (P < 2.79 × 10-5).
Results: African-specific (HLA-DQA1*03:01-HLA-DQB1*02:01) and known European-ancestry HLA haplotypes (HLA-DRB1*03:01-HLA-DQA1*05:01-HLA-DQB1*02:01, HLA-DRB1*04:01-HLA-DQA1*03:01-HLA-DQB1*03:02) were significantly associated with type 1 diabetes risk. Among European-ancestry defined non-HLA risk loci, six risk loci were significantly associated with type 1 diabetes in subjects of African ancestry. An African-specific GRS provided strong prediction of type 1 diabetes risk (area under the curve 0.871), performing significantly better than a European-based GRS and two polygenic risk scores in independent discovery and validation cohorts.
Conclusions: Genetic risk of type 1 diabetes includes ancestry-specific, disease-associated variants. The GRS developed here provides improved prediction of type 1 diabetes in African-ancestry subjects and a means to identify groups of individuals who would benefit from immune monitoring for early detection of islet autoimmunity.
© 2019 by the American Diabetes Association.
Figures

Regional type 1 diabetes association plots for non-HLA risk loci identified in African Americans. LocusZoom plots for 2q33.2 (A); 6q22.32 (B); 10q23.31, observed association (rs10788599) is in close proximity (∼152 kb) but independent from reported intronic SNP (rs12416116) in European-ancestry populations (C); 11p15.5 (D); 12q13.2 (E); and 17q12 (F) (25). The most significant type 1 diabetes–associated SNP at each locus is plotted (purple). Each symbol on the plot represents a single SNP included in the type 1 diabetes association test (African-ancestry participants); the symbol color corresponds to the degree of LD, with the most significant SNP colored purple. The most significant type 1 diabetes–associated SNP reported in the study by Onengut-Gumuscu et al. (6) is indicated with a yellow-colored star with the exception of 12q13.2, where rs705705 is the index SNP for both populations, indicated with a purple diamond. Type 1 diabetes 99% credible SNPs identified in European-ancestry populations that passed quality control in African-ancestry data are marked with triangles, and all other SNPs are marked with a circle.

Type 1 diabetes risk prediction in African-ancestry subjects using a GRS. The red curve is for the prediction using an African-ancestry GRS (AA GRS), and the black curve is for the prediction using a European-ancestry GRS (EUR GRS) (7).
Similar articles
-
A multi-ancestry genome-wide association study in type 1 diabetes.
Michalek DA, Tern C, Zhou W, Robertson CC, Farber E, Campolieto P, Chen WM, Onengut-Gumuscu S, Rich SS. Michalek DA, et al. Hum Mol Genet. 2024 May 18;33(11):958-968. doi: 10.1093/hmg/ddae024. Hum Mol Genet. 2024. PMID: 38453145 Free PMC article.
-
HLA-DRB, -DQA, and DQB alleles and haplotypes in Iranian patients with diabetes mellitus type I.
Rabbani A, Abbasi F, Taghvaei M, Rabbani B, Moradi B, Shakiba Y, Rezaei N, Amirzargar A. Rabbani A, et al. Pediatr Diabetes. 2013 Aug;14(5):366-71. doi: 10.1111/j.1399-5448.2012.00869.x. Epub 2012 May 14. Pediatr Diabetes. 2013. PMID: 22583516
-
Association of HLA-DRB1 and -DQ Alleles and Haplotypes with Type 1 Diabetes in Jordanians.
Khdair SI, Jarrar W, Jarrar YB, Bataineh S, Al-Khaldi O. Khdair SI, et al. Endocr Metab Immune Disord Drug Targets. 2020;20(6):895-902. doi: 10.2174/1871530319666191119114031. Endocr Metab Immune Disord Drug Targets. 2020. PMID: 31742498
-
Utility of genetic risk scores in type 1 diabetes.
Luckett AM, Weedon MN, Hawkes G, Leslie RD, Oram RA, Grant SFA. Luckett AM, et al. Diabetologia. 2023 Sep;66(9):1589-1600. doi: 10.1007/s00125-023-05955-y. Epub 2023 Jul 13. Diabetologia. 2023. PMID: 37439792 Free PMC article. Review.
Cited by
-
Deutsch AJ, Stalbow L, Majarian TD, Mercader JM, Manning AK, Florez JC, Loos RJF, Udler MS. Deutsch AJ, et al. Diabetes Care. 2023 Apr 1;46(4):794-800. doi: 10.2337/dc22-1833. Diabetes Care. 2023. PMID: 36745605 Free PMC article.
-
Diabetes Study of Children of Diverse Ethnicity and Race: Study design.
Redondo MJ, Harrall KK, Glueck DH, Tosur M, Uysal S, Muir A, Atkinson EG, Shapiro MR, Yu L, Winter WE, Weedon M, Brusko TM, Oram R, Vehik K, Hagopian W, Atkinson MA, Dabelea D; DISCOVER Study Group. Redondo MJ, et al. Diabetes Metab Res Rev. 2024 Mar;40(3):e3744. doi: 10.1002/dmrr.3744. Epub 2023 Oct 27. Diabetes Metab Res Rev. 2024. PMID: 37888801 Free PMC article.
-
Type 1 diabetes in diverse ancestries and the use of genetic risk scores.
Redondo MJ, Gignoux CR, Dabelea D, Hagopian WA, Onengut-Gumuscu S, Oram RA, Rich SS. Redondo MJ, et al. Lancet Diabetes Endocrinol. 2022 Aug;10(8):597-608. doi: 10.1016/S2213-8587(22)00159-0. Epub 2022 Jun 17. Lancet Diabetes Endocrinol. 2022. PMID: 35724677 Free PMC article. Review.
-
A multi-ancestry genome-wide association study in type 1 diabetes.
Michalek DA, Tern C, Zhou W, Robertson CC, Farber E, Campolieto P, Chen WM, Onengut-Gumuscu S, Rich SS. Michalek DA, et al. Hum Mol Genet. 2024 May 18;33(11):958-968. doi: 10.1093/hmg/ddae024. Hum Mol Genet. 2024. PMID: 38453145 Free PMC article.
-
Szczerbinski L, Mandla R, Schroeder P, Porneala BC, Li JH, Florez JC, Mercader JM, Udler MS, Manning AK. Szczerbinski L, et al. Sci Rep. 2024 Nov 6;14(1):26895. doi: 10.1038/s41598-024-74730-9. Sci Rep. 2024. PMID: 39505999 Free PMC article.
References
-
- Genuth S, Alberti KG, Bennett P, et al. .; Expert Committee on the Diagnosis and Classification of Diabetes Mellitus . Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26:3160–3167 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P01 AI042288/AI/NIAID NIH HHS/United States
- DP3 DK085678/DK/NIDDK NIH HHS/United States
- U01 DP000248/DP/NCCDPHP CDC HHS/United States
- U01 DK062418/DK/NIDDK NIH HHS/United States
- UL1 TR000062/TR/NCATS NIH HHS/United States
- U18 DP002709/DP/NCCDPHP CDC HHS/United States
- UL1 TR002319/TR/NCATS NIH HHS/United States
- UL1 TR000077/TR/NCATS NIH HHS/United States
- U01 DP000250/DP/NCCDPHP CDC HHS/United States
- P30 DK057516/DK/NIDDK NIH HHS/United States
- HIR 10-001/HX/HSRD VA/United States
- U01 DP000247/DP/NCCDPHP CDC HHS/United States
- R01 DK046635/DK/NIDDK NIH HHS/United States
- R01 HG008965/HG/NHGRI NIH HHS/United States
- U18 DP002710/DP/NCCDPHP CDC HHS/United States
- R01 DK096926/DK/NIDDK NIH HHS/United States
- UL1 TR000154/TR/NCATS NIH HHS/United States
- U18 DP002714/DP/NCCDPHP CDC HHS/United States
- P30 DK079626/DK/NIDDK NIH HHS/United States
- T32 LM012416/LM/NLM NIH HHS/United States
- U01 DP000244/DP/NCCDPHP CDC HHS/United States
- UL1 TR001417/TR/NCATS NIH HHS/United States
- UL1 TR000423/TR/NCATS NIH HHS/United States
- P01 AR049084/AR/NIAMS NIH HHS/United States
- U01 DP000246/DP/NCCDPHP CDC HHS/United States
- U01 DP000254/DP/NCCDPHP CDC HHS/United States
- U18 DP002708/DP/NCCDPHP CDC HHS/United States
- U01 DK062431/DK/NIDDK NIH HHS/United States
- R01 DK106718/DK/NIDDK NIH HHS/United States
- P30 DK017047/DK/NIDDK NIH HHS/United States